Sign in
4

Changes in Ownership

Cytosorbents Corp Filed Acc 0001104659-24-042772

Options or other derivatives

  • Chief Executive Officer acquired 129,998 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Chan Phillip P. Chief Executive Officer 2024-03-29 Grant or award · Stock Option (Right to Buy) +129,998 129,998 D
Loading xslF345X05/tm2410664-1_4seq1.xml…